D-0895-2018 Class II Terminated

Recalled by SCA Pharmaceuticals, LLC — Windsor, CT

FDA drug recall D-0895-2018 was initiated by SCA Pharmaceuticals, LLC on Jun 14, 2018 and is designated Class II. Reason for recall: Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage. The recall status is terminated (terminated Feb 4, 2019). Affected quantity: 492 bags.

Recall Details

Product Type
Drugs
Report Date
Jul 11, 2018
Initiation Date
Jun 14, 2018
Termination Date
Feb 4, 2019
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
492 bags

Product Description

Fentanyl (as citrate) 10 mcg/mL in 0.9% Sodium Chloride 250 mL bag, SCA Pharmaceuticals, LLC, Windsor, CT

Reason for Recall

Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.

Distribution Pattern

Product was distributed throughout the United States.

Code Information

Lot # 20180328@19, 20180328@31, 20180328@39, 20180328@49, 20180328@53, 20180328@58, 20180323@9, 20180327@33, Exp 6/26/2018

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0895-2018
openFDA file date
Oct 23, 2026
Loaded by RegDataLab
Oct 25, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.